Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Uterine Cervical Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Pancreatic cancer, adult 2Urinary Bladder Neoplasms 1Pancreatic Neoplasms 1Neoplasms 1Colorectal Neoplasms 1Adenoma, Islet Cell 1

Interventions

Gemcitabine 8Cystectomy 6Cisplatin 5Mitomycin 3toripalimab 2tislelizumab 2disitamab vedotin 2Radiotherapy 2Radiosurgery 2Magnetic Resonance Spectroscopy 2Drug Therapy 2zimberelimab 1trilaciclib 1sacituzumab govitecan 1nimotuzumab 1entinostat 1durvalumab 1cemiplimab 1Transurethral Resection of Bladder 1Therapeutics 1Synapsins 1Saline Solution 1Radiotherapy, Intensity-Modulated 1RC48 antibody 1Olive Oil 1Niacinamide 1Niacin 1Music Therapy 1Liquid Biopsy 1Immunonutrition Diet 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Urinary Bladder Neoplasms × nimotuzumab × Clear all
NCT07053735 2025-07-08

An Exploratory Clinical Study of Nimotuzumab in Bladder - Sparing Chemoradiotherapy for Muscle - Invasive Bladder Cancer

Peking University First Hospital

Phase 1 Not yet recruiting
30 enrolled
Genitourinary

Urinary Bladder Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡